Medicine RSS Search Engine

Respiratory Medicine News Respiratory Medicine OPML fileThis is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. Respiratory Medicine News RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. subscribe with MyMedWormSubscribe to this data using MyMedWorm.subscribe with GoogleReaderSubscribe to this data using GoogleReader.subscribe with BloglinesSubscribe to this data using Bloglines.subscribe with MyYahooSubscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 28.

In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus
Krishnan-Natesan S, Wu W, Cutright JL, Chandrasekar PH
Source: The Aspergillus Website - articles - September 7, 2012 Category: Respiratory Medicine Source Type: news

First reported case of azole-resistant Aspergillus fumigatus due to TR/L98H mutation in Germany
Rath PM, Buchheidt D, Spiess B, Arfanis E, Buer J, Steinmann J
Source: The Aspergillus Website - articles - September 7, 2012 Category: Respiratory Medicine Source Type: news

Utilization of Omeprazole to Augment Subtherapeutic Voriconazole Concentrations for Treatment of Aspergillus: Case Report and Review of the Literature
Boyd NK, Zoellner CL, Swancutt MA, Bhavan KP
Source: The Aspergillus Website - articles - September 7, 2012 Category: Respiratory Medicine Source Type: news

Epidemiology and Visual Outcomes in Patients With Infectious Scleritis
Hodson KL, Galor A, Karp CL, Davis JL, Albini TA, Perez VL, Miller D, Forster RK
Source: The Aspergillus Website - articles - September 7, 2012 Category: Respiratory Medicine Source Type: news

Detection of Urinary Excreted Fungal Galactomannan-like Antigens for Diagnosis of Invasive Aspergillosis
Dufresne SF, Datta K, Li X, Dadachova E, Staab JF, Patterson TF, Feldmesser M, Marr KA
Source: The Aspergillus Website - articles - September 7, 2012 Category: Respiratory Medicine Source Type: news

The significance of computed tomographic findings in the diagnosis of fungus ball in the paranasal sinuses
Chen JC, Ho CY
Source: The Aspergillus Website - articles - September 7, 2012 Category: Respiratory Medicine Source Type: news

Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis
Zou M, Tang L, Zhao S, Zhao Z, Chen L, Chen P, Huang Z, Li J, Chen L, Fan X
Source: The Aspergillus Website - articles - September 7, 2012 Category: Respiratory Medicine Source Type: news

THE MIRB FERRISIDEROPHORE TRANSPORTER OF ASPERGILLUS FUMIGATUS: STRUCTURAL REQUIREMENTS FOR ACTIVITY
Raymond-Bouchard I, Carroll CS, Nesbitt JR, Henry KA, Pinto LJ, Moinzadeh M, Scott JK, Moore MM
Source: The Aspergillus Website - articles - September 7, 2012 Category: Respiratory Medicine Source Type: news

The Aspergillus fumigatus Protein GliK Protects Against Oxidative Stress and is Essential for Gliotoxin Biosynthesis
Gallagher L, Owens RA, Dolan SK, O'Keeffe G, Schrettl M, Kavanagh K, Jones GW, Doyle S
Source: The Aspergillus Website - articles - September 7, 2012 Category: Respiratory Medicine Source Type: news

Seven-year surveillance of nosocomial invasive aspergillosis in a French University Hospital
Garnaud C, Brenier-Pinchart MP, Thiebaut-Bertrand A, Hamidfar R, Quesada JL, Bosseray A, Lebeau B, Mallaret MR, Maubon D, Saint-Raymond C, Pinel C, Hincky V, Plantaz D, Cornet M, Pelloux H
Source: The Aspergillus Website - articles - September 7, 2012 Category: Respiratory Medicine Source Type: news

Proof-of-principle for SERS imaging of Aspergillus nidulans hyphae using in vivo synthesis of gold nanoparticles
Prusinkiewicz MA, Farazkhorasani F, Dynes JJ, Wang J, Gough KM, Kaminskyj SG
Source: The Aspergillus Website - articles - September 7, 2012 Category: Respiratory Medicine Source Type: news

Yosemite hantavirus – key questions answered
Six cases of hantavirus from Yosemite National Park have been confirmed and two have died. What is it, how is it spread and what should you do if you think you've been exposed?What is a hantavirus?Hantaviruses are a group of viruses that can cause a life-threatening disease in people with symptoms similar to influenza. They are carried by some rodents, but do not make the animals sick.A person infected by hantavirus is at risk of developing hantavirus pulmonary syndrome, a severe and sometimes fatal respiratory condition. HPS, such as the current outbreak in California, only occurs in North and South America, but hantaviru...
Source: Guardian Unlimited Science - September 7, 2012 Category: Science Tags: United States World news Infectious diseases Health guardian.co.uk Microbiology Society Q & amp;As Science Source Type: news

Promising New Drug Target For Inflammatory Lung Diseases
The naturally occurring cytokine interleukin-18, or IL-18, plays a key role in inflammation and has been implicated in serious inflammatory diseases for which the prognosis is poor and there are currently limited treatment options. Therapies targeting IL-18 could prove effective against inflammatory diseases of the lung including bronchial asthma and chronic obstructive pulmonary disease (COPD), as described in a review article published in Journal of Interferon & Cytokine Research, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers...
Source: Health News from Medical News Today - September 7, 2012 Category: Consumer Health News Tags: Respiratory / Asthma Source Type: news

dornase alpha, Pulmozyme
Title: dornase alpha, PulmozymeCategory: MedicationsCreated: 12/14/2000 9:46:00 AMLast Editorial Review: 9/7/2012 12:00:00 AM
Source: MedicineNet Lungs General - September 7, 2012 Category: Respiratory Medicine Source Type: news

zafirlukast, Accolate
Title: zafirlukast, AccolateCategory: MedicationsCreated: 4/19/1999 11:07:00 PMLast Editorial Review: 9/7/2012 12:00:00 AM
Source: MedicineNet Asthma General - September 7, 2012 Category: Respiratory Medicine Source Type: news

Study Finds Increase In Number Of Non-Smokers Being Diagnosed With Lung Cancer
There has been an increase in the number of non-smokers being diagnosed with non-small cell lung cancer, according to new findings. The report, which was presented on the 4th September 2012 at the European Respiratory Society's Annual Congress in Vienna, also found an increase in the number of women being diagnosed with the condition. Little is known about risk factors that can cause lung cancer in non-smokers, although recently the World Health Organization (WHO) confirmed earlier this year that exhaust fumes from diesel engines were a cause of lung cancer...
Source: Health News from Medical News Today - September 7, 2012 Category: Consumer Health News Tags: Lung Cancer Source Type: news

Human lungs 'brush' themselves clean of contaminants
Human lungs contain a tiny network of constantly moving "brushes" that flush contaminants out of the respiratory system, according to research conducted by scientists from the University of North Carolina and published in the journal Science. Scientists have known...
Source: NaturalNews.com - September 7, 2012 Category: Consumer Health Advice Source Type: news

Further data for QVA149 (indacaterol/glycopyrronium), glycopyrronium, and indacaterol presented at conference
Source: BioSpace Area: News Novartis has presented further data from its IGNITE Phase III clinical trial programme, which is evaluating QVA149 (fixed-dose combination of indacaterol maleate/glycopyrronium bromide) in the treatment of COPD, at the European Respiratory Society (ERS) Congress.   ILLUMINATE was a multicentre study comparing QVA149 110/50mcg to salmeterol/fluticasone 50/500mcg twice-daily over 26 weeks in patients with COPD. The study met its primary endpoint by demonstrating that the mean FEV1 area under the curve (AUC) for 0-12hr at Week 26 was significantly higher with QVA149 compared to salmetero...
Source: NeLM - News - September 7, 2012 Category: Drugs & Pharmacology Source Type: news

CADTH review: Naloxone for respiratory depression in patients with drug or addiction issues - safety and guidelines
Source: Canadian Agency for Drugs and Technologies in Health (CADTH) Area: News This rapid review by the Canadian Agency for Drugs and Technologies in Health (CADTH) examines the evidence on safety of naloxone for the treatment of respiratory depression in patients with polypharmacy intoxication or opioid dependence, and the guidelines available for its use for this indication.   A limited search of the literature identified one evidence-based guideline, developed by the American Psychiatric Association (APA) in 2006. This recommends that the dose of naloxone for reversing respiratory depression in patients with ...
Source: NeLM - News - September 7, 2012 Category: Drugs & Pharmacology Source Type: news

Phthalates may be asthma trigger
Research suggests that exposure to two phthalates may be a trigger for asthma-related airway inflammation.
Source: MedWire News - Respiratory - September 6, 2012 Category: Respiratory Medicine Source Type: news

AAP urges snoring screening for all children
All children and adolescents should be screened for snoring as part of routine health-maintenance visits and polysomnography considered for those with co-occurring symptoms such as daytime sleepiness, according to guidelines from the AAP.
Source: MedWire News - Respiratory - September 6, 2012 Category: Respiratory Medicine Source Type: news

Phthalates may be asthma trigger
Research suggests that exposure to two phthalates may be a trigger for asthma-related airway inflammation.
Source: MedWire News - Respiratory - September 6, 2012 Category: Respiratory Medicine Source Type: news

Soup Could Reduce Asthma Risk In Kids
A new study will be conducted by researchers at the University of Aberdeen to reveal whether soups enhanced with food that contains vitamin E may help reduce the chance of childhood asthma. Baxter Food Group in Scotland is working closely in collaboration with the experts to develop 3 soups containing ingredients with high levels of vitamin E. The intention of the authors is to increase the amount of vitamin E pregnant women are consuming. The national average is currently 8mg per day, and the experts say 15mg per day would be more beneficial...
Source: Health News from Medical News Today - September 6, 2012 Category: Consumer Health News Tags: Respiratory / Asthma Source Type: news

Childhood virus RSV shows promise against adult cancer
RSV, a common respiratory virus in infants and young children, is being studied as a safe, effective way to treat cancer. RSV already shows promise in anti-cancer trials overseas. US clinical trials could be on the horizon.
Source: ScienceDaily Headlines - September 6, 2012 Category: Science Source Type: news

Rapid Response In Cases Of Smoke Poisoning
The main cause of cyanide poisoning is smoke inhalation in closed spaces during fires. Cyanides, the salts of hydrocyanic acid, inhibit cellular respiration and may lead to coma or death. The rapid administration of a cyanide antidote is essential for successful treatment. Previously, detecting cyanide in the blood took up to an hour and could only be performed in the laboratory, a lengthy process that is poorly suited for emergency situations. As a result, emergency doctors and paramedics are forced to administer antidotes based solely on presumptive diagnoses...
Source: Health News from Medical News Today - September 6, 2012 Category: Consumer Health News Tags: Respiratory / Asthma Source Type: news

Asthma Treatment With Omalizumab (Xolair®), New Data Shows Benefits
New data analyses presented at the European Respiratory Society (ERS) Annual Congress in Vienna show that long-term treatment with omalizumab (Xolair®) significantly improves a range of outcomes for people with severe persistent allergic asthma, a chronic condition affecting an estimated 14,315 people in the UK4. Asthma can be a devastating condition, causing an average of three deaths in the UK every day, 90% of which are preventable with optimal management5...
Source: Health News from Medical News Today - September 6, 2012 Category: Consumer Health News Tags: Respiratory / Asthma Source Type: news

Childhood virus RSV shows promise against adult cancer
(University of Texas Health Science Center at San Antonio) RSV, a common respiratory virus in infants and young children, is being studied as a safe, effective way to treat cancer. RSV's cancer-fighting properties were discovered at The University of Texas Health Science Center San Antonio. RSV already shows promise in anti-cancer trials overseas. US clinical trials could be on the horizon.
Source: EurekAlert! - Medicine and Health - September 6, 2012 Category: Global & Universal Source Type: news

Actor's Death Highlights Need for Portable Emergency Oxygen
FRISCO, Texas, Sept. 5, 2012 (GLOBE NEWSWIRE) -- OxySure Systems, Inc. (OTCBB:OXYS) , a medical technology company focused on the design, manufacture and distribution of specialty medical and respiratory solutions, has developed a portable emergency oxygen system for lay person use that could prevent oxygen-related damage that can occur during medical emergencies.
Source: Medical News (via PRIMEZONE) - September 5, 2012 Category: Pharmaceuticals Source Type: news

Ivacaftor Improves Lung Function And Symptoms In Cystic Fibrosis Patients With Specific Genetic Mutation
Ivacaftor, a novel oral agent that potentiates a membrane channel blocked in patients aged six years and older with cystic fibrosis caused by the G551D mutation, significantly improves lung function and reduces pulmonary exacerbations, according to phase 3 data reported at the European Respiratory Society's Annual Congress 2012, Vienna, on Monday (3 September 2012). Open label follow-up showed the improved lung function and good tolerability was maintained with continued treatment...
Source: Health News from Medical News Today - September 5, 2012 Category: Consumer Health News Tags: Cystic Fibrosis Source Type: news

omalizumab, Xolair
Title: omalizumab, XolairCategory: MedicationsCreated: 5/27/2004 8:16:00 AMLast Editorial Review: 9/5/2012 12:00:00 AM
Source: MedicineNet Asthma General - September 5, 2012 Category: Respiratory Medicine Source Type: news

Asthma Treatment Tiotropium Receives Positive Results
First Phase III Data for Tiotropium in Symptomatic Asthma Patients Treated with ICS/LABA Published in the New England Journal of Medicine. Data simultaneously presented at the 2012 European Respiratory Society Congress Boehringer Ingelheim presented today the first data from the Phase III UniTinA-asthma™ program...
Source: Health News from Medical News Today - September 5, 2012 Category: Consumer Health News Tags: Respiratory / Asthma Source Type: news

Study Sheds Light On Lung Cancers That Are Undetected By Radiograph
New research has revealed why some lung cancers are undetected by radiograph and helped to identify the type of people who may be at risk of this form of the disease. The findings was presented on Monday (3 September 2012) at the European Respiratory Society's Annual Congress in Vienna. There has been no significant reduction in lung cancer mortality rates in recent years. Chest radiographs can be used to screen for lung cancer...
Source: Health News from Medical News Today - September 5, 2012 Category: Consumer Health News Tags: Lung Cancer Source Type: news

Improved Diagnosis Of Lung Disease: New Global Benchmarks
New research has established the first global benchmarks for assessing lung function across the entire life span. The lung growth charts will help healthcare professionals better understand lung disease progression and help raise awareness of lung disease, which is the world's leading cause of death.[1] The research was presented on Monday (3 September 2012) at the European Respiratory Society's Annual Congress in Vienna...
Source: Health News from Medical News Today - September 5, 2012 Category: Consumer Health News Tags: Respiratory / Asthma Source Type: news

Children Taking Steroids For Asthma Are Slightly Shorter Than Peers
Children who use inhaled steroid drugs for asthma end up slightly shorter at their full adult height than children who don't use the drugs, new results from a comprehensive asthma study show. The findings were presented Sept. 3 at the European Respiratory Society meeting in Vienna, Austria, and published online in the New England Journal of Medicine. The study's senior author is Robert C. Strunk, MD, the Donald Strominger Professor of Pediatrics at Washington University School of Medicine in St. Louis...
Source: Health News from Medical News Today - September 5, 2012 Category: Consumer Health News Tags: Respiratory / Asthma Source Type: news

Intermittent ribavirin aerosol advised for cancer patients with RSV
NEW YORK (Reuters Health) - For respiratory syncytial virus (RSV) infections in patients with blood cancers, aerosolized ribavirin can be given intermittently rather than continuously, a new study shows.
Source: Modern Medicine - September 5, 2012 Category: Journals (General) Source Type: news

Horizon scanning: Analyses of ongoing RECAP study of pirfenidone (EsbrietT) for idiopathic pulmonary fibrosis presented at conference
Source: BioSpace Area: News Biospace has reported on new analyses of data from the RECAP extension study of pirfenidone (EsbrietT) which were presented at the 2012 Annual Congress of the European Respiratory Society (ERS) in Vienna.   The RECAP study (n=603) is an ongoing open-label extension study evaluating the long-term administration of pirfenidone in patients who received placebo in the Phase III CAPACITY program (studies 004 and 006) which evaluated pirfenidone in idiopathic pulmonary fibrosis (IPF) patients with mild to moderate impairment in lung function (n=626).   This new analyses focused on ...
Source: NeLM - News - September 5, 2012 Category: Drugs & Pharmacology Source Type: news

More Non-Smokers Are Being Diagnosed With Lung Cancer
New research has found that the number of non-smokers being diagnosed with non-small cell lung cancer has increased. The study, which will be presented today at the European Respiratory Society's Annual Congress in Vienna, also discovered that the the number of women being diagnosed with this type of cancer is increasing as well...
Source: Health News from Medical News Today - September 4, 2012 Category: Consumer Health News Tags: Lung Cancer Source Type: news

Studies Suggest A Strong Link Between Sleep Apnea And Cancer Mortality
A new study, an addition to a trial from earlier in the year, was presented at the European Respiratory Society's (ERS) Annual Congress in Vienna today and reveals that sleep apnea is linked to a higher risk of dying from cancer. Sleep apnea is when a person has abnormal pauses in breathing or very low breathing during sleep. Two additional trials were also shown at the the Congress and highlighted the association between cancer and sleep apnea. For the first trial, the experts studied more than 5,600 patients from 7 sleep facilities in Spain...
Source: Health News from Medical News Today - September 4, 2012 Category: Consumer Health News Tags: Sleep / Sleep Disorders / Insomnia Source Type: news

Problems Among Parents Can Harm Children's Asthma Treatment Adherence
According to a study presented at the European Respiratory Society's Annual Congress in Vienna on September 3, 2012, children's asthma symptoms can worsen if there are problems among their parents at home. Although many asthma patients do not take their medication when and how they are supposed to, the reason for this, prior to now, has not been clear. Now, the experts have looked into the most common reasons that physicians believe are behind the patients not taking their medication correctly...
Source: Health News from Medical News Today - September 4, 2012 Category: Consumer Health News Tags: Respiratory / Asthma Source Type: news

Increase in respiratory symptoms following volcanic eruption
Exposure to volcanic ash can increase respiratory symptoms such as an extreme cough, or phlegm, according to a new study.
Source: ScienceDaily Headlines - September 4, 2012 Category: Science Source Type: news

Smoking History Can Predict Survival Time In COPD
Identifying an individual's the smoking history could help doctors to predict survival time in people with COPD. A new study, which was presented today (4 September 2012) at the European Respiratory Society's Annual Congress in Vienna, has identified that the measurement, pack-years, is a strong predictor for mortality in COPD. Chronic obstructive pulmonary disease (COPD) is a term given to a group of conditions which cause a gradual restriction of airflow which gives people difficulty breathing...
Source: Health News from Medical News Today - September 4, 2012 Category: Consumer Health News Tags: COPD Source Type: news

Smoking And Natural Disasters: Christchurch Residents Increase Tobacco Consumption Post-Earthquake
The prevalence of smoking in Christchurch, New Zealand, increased following the 2010 earthquake, according to a new study. The results of the study was presented today (4 September 2012) at the European Respiratory Society's Annual Congress in Vienna. The 7.1-magnitude Christchurch earthquake, and subsequent aftershocks, have caused a huge amount of damage and dramatically changed the social, working and living conditions for residents in the city...
Source: Health News from Medical News Today - September 4, 2012 Category: Consumer Health News Tags: Smoking / Quit Smoking Source Type: news

Increase In Respiratory Symptoms Following Volcanic Eruption
Exposure to volcanic ash can increase respiratory symptoms such as an extreme cough, or phlegm, according to a new study. The research, which was presented today (4 September 2012) at the European Respiratory Society's Annual Congress in Vienna, investigated the effects of living close to the Icelandic Volcano, Eyjafjallajökull. Eyjafjallajökull erupted in April 2010 and created a huge ash cloud which spread across Europe, causing widespread disruption to air travel on the continent...
Source: Health News from Medical News Today - September 4, 2012 Category: Consumer Health News Tags: Respiratory / Asthma Source Type: news

Discovery Labs to Present at the Stifel Nicolaus Healthcare Conference 2012
WARRINGTON, Pa., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, will be presenting at the Stifel Nicolaus Healthcare Conference 2012 on Thursday, September 6, 2012, at 9:45 AM EDT. The conference will be held September 5 - 6, 2012 at the Four Seasons Hotel Boston, in Boston, Massachusetts.
Source: Medical News (via PRIMEZONE) - September 4, 2012 Category: Pharmaceuticals Source Type: news

Tiotropium significantly reduces asthma exacerbations
Tiotropium delivered by the Respimat SMI significantly increased the time to first severe asthma exacerbation and in addition, reduced the risk of exacerbations (P = 0.03) in adults who remain symptomatic despite treatment with at least inhaled corticosteroids (ICS)/long-acting beta-agonists (LABA) in phase III PrimoTinA-asthma™ studies, presented today at the 2012 European Respiratory Society (ERS) congress. Tiotropium also significantly improved lung function in symptomatic asthma patients on ICS/LABA.(2)
Source: Pharmacy Europe - September 4, 2012 Category: Drugs & Pharmacology Source Type: news

Asthma Drug Shown to Stunt Growth
Title: Asthma Drug Shown to Stunt GrowthCategory: Health NewsCreated: 9/4/2012 2:13:00 PMLast Editorial Review: 9/4/2012 12:00:00 AM
Source: MedicineNet Asthma General - September 4, 2012 Category: Respiratory Medicine Source Type: news

Breathable Treatment To Help Prevent Asthma Attacks
Details of a treatment that could help asthmatics fight infections that trigger 80% of asthma attacks, developed by University of Southampton spin-out company Synairgen, was presented to European respiratory experts on Sunday 2 September. The study provides the first evidence that boosting asthmatics' immune systems can help reduce the number of asthma attacks due to the common cold and other viral infections for the 5.4 million asthmatics in the UK...
Source: Health News from Medical News Today - September 4, 2012 Category: Consumer Health News Tags: Respiratory / Asthma Source Type: news

Balance Problems May Aggravate Asthma Symptoms
Asthma patients could be at a higher risk of worsening symptoms due to problems with their balance, according to new research. The study was presented at the European Respiratory Society's Annual Congress in Vienna. Researchers aimed to assess the link between asthma, anxiety and balance. Anxiety and imbalance are closely related. Muscles and joints are controlled by signals from the brain, which are, in turn, sent from stimuli from the eyes and inner ear. This function is also controlled by the limbic system in the brain, which is additionally responsible for emotions, such as anxiety...
Source: Health News from Medical News Today - September 4, 2012 Category: Consumer Health News Tags: Respiratory / Asthma Source Type: news

Degree Of Muscle Wasting In Critically Ill Patients Determined By New Technique
Researchers have identified a new technique that can help determine the severity of muscle loss in critically ill patients. The breakthrough could lead to new research to help prevent muscle-wasting and new therapeutic interventions to help treat critically ill patients. The results of the study were presented at the European Respiratory Society's Annual Congress in Vienna, 31st August - 5th September 2012. Patients who are critically ill with multi-organ failure often have significant muscle wasting after recovering from their illness...
Source: Health News from Medical News Today - September 4, 2012 Category: Consumer Health News Tags: Bones / Orthopedics Source Type: news

e-Cigarettes Can Damage The Lungs: Warning From Experts
New research has shown that despite electronic cigarettes being marketed as a potentially safer alternative to normal cigarettes, they are still causing harm to the lungs. A new study, presented at the European Respiratory Society's Annual Congress in Vienna, has added new evidence to the debate over the safety of alternative nicotine-delivery products. Electronic cigarettes are devices that deliver nicotine through a vapour, rather than smoke. There is no combustion involved but the nicotine in the device is still derived from tobacco...
Source: Health News from Medical News Today - September 4, 2012 Category: Consumer Health News Tags: Smoking / Quit Smoking Source Type: news